Intra-arterial thrombolysis in acute ischaemic stroke

Internal Medicine Journal

Volumn 35, Issue 5, 2005, Pages 300-302

  Jones, Michael M ^a   Nogajski, J H ^a   Faulder, K ^a   Harrington, T ^a   Ng, P ^a   Storey, C E ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Intra arterial thrombolysis; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; INFARCTION, ANTERIOR CEREBRAL ARTERY; INFARCTION, MIDDLE CEREBRAL ARTERY; MIDDLE AGED; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR; VERTEBROBASILAR INSUFFICIENCY;

EID: 18744397198     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00830.x     Document Type: Article

References (12)

1. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C et al. Intra-arterial prourokinase for acute ischaemic stroke. The PROACT II study: a randomised controlled trial. Prolyse Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-11.
2. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley H, Gent M. PROACT a phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998; 29: 4-11.
3. The NINDSt-PA Stroke Study Group. Generalised efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997; 28: 2119-25.
4. The NINDSt-PA Stroke Study Group. Intracerebral haemorrhage after intravenous t-PA therapy for ischaemic stroke. Stroke 1997; 28: 2109-18.
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1025.
6. Hacke W, Kaste M, Fieschi C, Davlos A, Meier D, Larrue V et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke. Second European-Australasian Acute Stroke Study Investigators (ECASSII). Lancet 1998; 352: 1251.
7. Clark WM, Albers GW, for the ATLANTIS Stroke Study Investigators. The ATLANTIS Rt-PA (Alteplase) Acute Stroke Trial Final Results. Stroke 1999; 30: 234.
8. Clark WM, Albers GW, Madden KP, Hamilton S. The rt-PA (alteplase) 0-6 hour acute stroke trial, part A (A0276g); results of a double-blind, placebo-controlled multi-centre study. Thrombolytic therapy in acute ischaemic stroke study investigators. Stroke 2000; 31: 811-6.
9. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
10. Schellinger PD, Fiebach JB, Mohr A, Ringleb P, Jansen O, Hacke W. Thrombolytic therapy for ischaemic stroke - a review. Part II - Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging. Crit Care Med 2001; 29: 1819-25.
11. Ng PP, Randall T, Higashida RT, Cull SP, Malek R, Dowd CF et al. Intraarterial thrombolysis trials in acute ischaemic stroke. J Vase Interv Radiol 2004; 15: S77-85.
12. Adams HP, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein L et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American Stroke Association. Stroke 2003; 34: 1056-83.